查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1621573

尿液检查市场：按产品、检测类型、应用、最终用途 - 2025-2030 年全球预测

Urinalysis Market by Product (Consumables, Instruments), Test Type (Biochemical Urinalysis, Pregnancy & Fertility Tests, Sediment Urinalysis), Application, End-Use - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 192 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年尿液检查市值为43亿美元，预计2024年将达45.3亿美元，复合年增长率为5.76%，预计到2030年将达到63.7亿美元。

尿液检查涵盖范围广泛，重点是用于医学评估和疾病监测的尿液检查，既作为重要的诊断工具，又作为常规健康检查方法。这个过程对于早期发现糖尿病、肾臟疾病和尿道感染等疾病至关重要，有助于预防性医疗保健。该应用程式用途广泛，广泛应用于不同的人群，包括医院、诊断实验室和家庭。尿液检查的需求源于其非侵入性、易于操作以及提供丰富且重要的健康资讯的能力。根据市场洞察，该行业的成长主要是由慢性病盛行率上升、预防保健意识增强以及诊断方法技术进步所推动的。可携式、侵入性较小的检测套组的出现满足了对家庭监控解决方案不断增长的需求，并代表了一个巨大的潜在机会。然而，市场限制包括结果可能不准确以及需要使用更复杂的诊断工具进行交叉检验，从而增加了使用和解释的复杂性。此外，严格的监管要求和缺乏标准化等挑战可能会阻碍市场成长。创新领域已经成熟，例如透过人工智慧和机器学习演算法开发更准确和个人化的尿液检查，以及整合物联网 (IoT) 连接以增强即时资料监测和病人参与。尿液检查市场的本质是动态的，在技术和消费者对更容易获得的健康见解的需求的推动下，稳步转向以患者为中心的护理。希望利用这些趋势的公司应该优先进行研究，使尿液检查更加用户友好和准确，同时需要协调法规以克服障碍并扩大市场范围。

主要市场统计
基准年[2023] 43亿美元
预测年份 [2024] 45.3亿美元
预测年份 [2030] 63.7亿美元
复合年增长率（%） 5.76%

市场动态：揭示快速发展的尿液检查市场的关键市场洞察

供需的动态交互作用正在改变尿液检查市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 全球肾臟疾病和尿道感染盛行率不断上升
    • 政府积极致力于慢性病的早期筛检和管理
    • 临床实验室和医院越来越多地采用照护现场(POC) 系统
  • 市场限制因素
    • 产品召回问题
  • 市场机会
    • 肾臟生物标记和 smaRT-LAMP 系统的技术进步
    • 推出用于尿道感染筛检的自动分析仪
  • 市场挑战
    • 缺乏定期健康检查意识，缺乏熟练的化验技术人员

波特五力：驾驭尿液检查市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势、解决弱点并避免潜在的挑战，以确保更强大的市场地位。

PESTLE分析：了解尿液检查市场的外部影响

外部宏观环境因素在塑造尿液检查市场的表现动态方面发挥着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并为他们做出积极主动的决策做好准备。

市场占有率分析 了解尿液检查市场的竞争状况

尿液检查市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵尿液检查市场供应商绩效评估

FPNV定位矩阵是评估尿液检查市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製尿液检查市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，尿液检查市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开发：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、未开发地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点关注可望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，以帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 全球肾臟疾病和尿道感染的盛行率增加
      • 政府优先采取的早期筛检和管理倡议

慢性疾病

      • 临床实验室和医院越来越多地采用照护现场尿液检查系统
    • 抑制因素
      • 对产品召回的严重担忧
    • 机会
      • 肾臟生物标记和 smaRT-LAMP 系统的技术进步
      • 引进自动分析仪进行尿道感染感染筛检
    • 任务
      • 缺乏定期健康检查意识，缺乏熟练的检查人员
  • 市场区隔分析
    • 产品：广泛使用收集杯，方便、卫生地收集尿液样本进行医疗诊断
    • 最终用途：越来越多地用于临床实验室，用于各种疾病的筛检和诊断
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章尿液检查市场：分产品

  • 消耗品
    • 收集杯
    • 试剂
    • 尿液检查/试纸
  • 装置

第七章尿液检查市场：依检测类型

  • 尿液检查
  • 妊娠及不孕症检测
  • 尿液检查

第八章尿液检查市场：依应用分类

  • 糖尿病
  • 高血压
  • 肾臟疾病
  • 肝臟疾病
  • 尿道感染

第九章尿液检查市场：依最终用途分类

  • 临床实验室
  • 家庭保健
  • 医院
  • 研究和学术

第十章 北美及南美尿液检查市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十一章亚太尿液检查市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十二章 欧洲、中东和非洲尿液检查市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十三章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
    • AixMed 和 CorePlus 合作进行创新尿液分析研究
    • 丰田合成投资 Eurea 推进尿液分析技术
    • Medtronic)采取策略性倡议，透过新创企业解决尿失禁问题
  • 战略分析和建议

公司名单

  • 77 Elektronika Kft.
  • Abbott Laboratories
  • ACON Laboratories, Inc. by Inverness Medical
  • AdvaCare Pharma
  • Alphatec Scientific EIRL
  • Analyticon Biotechnologies GmbH by BRAIN Biotech AG
  • Anamol Laboratories Pvt. Ltd.
  • ARKRAY, Inc.
  • Beckman Coulter, Inc. by Danaher Corporation
  • Becton, Dickinson, and Company
  • Bio-Rad Laboratories, Inc.
  • Bioway Biotechnology Co., Ltd.
  • Cardinal Health, Inc.
  • Contec Medical Systems Co., Ltd.
  • Dirui Industrial Co., Ltd.
  • EKF DIAGNOSTICS HOLDINGS PLC
  • Erba Group
  • F. Hoffmann-La Roche Ltd.
  • Kova International, Inc. by LGC Limited
  • MACHEREY-NAGEL GmbH & Co. KG
  • Medsource Ozone Biomedicals Pvt. Ltd.
  • Quidel Corporation
  • Randox Laboratories Ltd.
  • Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • Siemens Healthcare GmbH
  • Sweet Cures Nutra
  • Sysmex Corporation
  • Teco Diagnostics
  • Thermo Fisher Scientific Inc.
  • URIT Medical Electronic Group Co., Ltd
  • Woodley Equipment Company Ltd.
Product Code: MRR-034B5003034D

The Urinalysis Market was valued at USD 4.30 billion in 2023, expected to reach USD 4.53 billion in 2024, and is projected to grow at a CAGR of 5.76%, to USD 6.37 billion by 2030.

Urinalysis encompasses a broad scope as both a critical diagnostic tool and a routine health check method, focusing on the examination of urine for medical assessment and disease monitoring. This process is essential for the early detection of diseases such as diabetes, kidney disorders, and urinary tract infections, contributing to preventive healthcare. The application spans across hospitals, diagnostic laboratories, and home-use settings, making it versatile and widely used across various demographics. The necessity of urinalysis stems from its non-invasive nature, ease of execution, and ability to provide a wealth of vital health information. Market insights reveal that the growth of this sector is primarily driven by the rising incidence of chronic diseases, increased awareness about preventive healthcare, and technological advancements in diagnostic methods. The advent of portable and minimally invasive urinalysis testing kits represents significant potential opportunities, catering to increasing demand for home-based monitoring solutions. However, market limitations include the potential for inaccurate results and the need for cross-verification with more sophisticated diagnostic tools, adding layers of complexity to use and interpretation. Furthermore, challenges such as stringent regulatory requirements and a lack of standardization can impede market growth. Areas ripe for innovation include the development of more accurate, personalized urinalysis tests through artificial intelligence and machine learning algorithms, and the integration of Internet of Things (IoT) connectivity to enhance real-time data monitoring and patient engagement. The nature of the urinalysis market is dynamic, with a steady shift towards patient-centric care, driven by technology and consumer demand for more accessible health insights. Companies aiming to capitalize on these trends should prioritize research into making urinalysis more user-friendly and accurate, while also working towards regulatory harmonization to overcome barriers and expand their market reach.

KEY MARKET STATISTICS
Base Year [2023] USD 4.30 billion
Estimated Year [2024] USD 4.53 billion
Forecast Year [2030] USD 6.37 billion
CAGR (%) 5.76%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Urinalysis Market

The Urinalysis Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Growing prevalence of kidney diseases and urinary tract infections worldwide
    • Favorable government initiatives for early screening and management of chronic diseases
    • Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
  • Market Restraints
    • Significant concern for product recall
  • Market Opportunities
    • Technological advancement in renal biomarker and smaRT-LAMP system
    • Emergence of automated analyzers for urinary tract infection screening
  • Market Challenges
    • Lack of awareness about routine health checkup and limited skilled laboratory workforce

Porter's Five Forces: A Strategic Tool for Navigating the Urinalysis Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Urinalysis Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Urinalysis Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Urinalysis Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Urinalysis Market

A detailed market share analysis in the Urinalysis Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Urinalysis Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Urinalysis Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Urinalysis Market

A strategic analysis of the Urinalysis Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Urinalysis Market, highlighting leading vendors and their innovative profiles. These include 77 Elektronika Kft., Abbott Laboratories, ACON Laboratories, Inc. by Inverness Medical, AdvaCare Pharma, Alphatec Scientific E.I.R.L., Analyticon Biotechnologies GmbH by BRAIN Biotech AG, Anamol Laboratories Pvt. Ltd., ARKRAY, Inc., Beckman Coulter, Inc. by Danaher Corporation, Becton, Dickinson, and Company, Bio-Rad Laboratories, Inc., Bioway Biotechnology Co., Ltd., Cardinal Health, Inc., Contec Medical Systems Co., Ltd., Dirui Industrial Co., Ltd., EKF DIAGNOSTICS HOLDINGS PLC, Erba Group, F. Hoffmann-La Roche Ltd., Kova International, Inc. by LGC Limited, MACHEREY-NAGEL GmbH & Co. KG, Medsource Ozone Biomedicals Pvt. Ltd., Quidel Corporation, Randox Laboratories Ltd., Shenzhen Mindray Bio-Medical Electronics Co., Ltd., Siemens Healthcare GmbH, Sweet Cures Nutra, Sysmex Corporation, Teco Diagnostics, Thermo Fisher Scientific Inc., URIT Medical Electronic Group Co., Ltd, and Woodley Equipment Company Ltd..

Market Segmentation & Coverage

This research report categorizes the Urinalysis Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Consumables and Instruments. The Consumables is further studied across Collection Cups, Reagents, and Urine Strips/Dipsticks.
  • Based on Test Type, market is studied across Biochemical Urinalysis, Pregnancy & Fertility Tests, and Sediment Urinalysis.
  • Based on Application, market is studied across Diabetes, Hypertension, Kidney Diseases, Liver Diseases, and Urinary Tract Infections.
  • Based on End-Use, market is studied across Clinical Laboratories, Home Healthcare, Hospitals, and Research & Academics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Growing prevalence of kidney diseases and urinary tract infections worldwide
      • 5.1.1.2. Favorable government initiatives for early screening and management of

chronic diseases

      • 5.1.1.3. Rising adoption of point-of-care urinalysis systems in clinical laboratories and hospitals
    • 5.1.2. Restraints
      • 5.1.2.1. Significant concern for product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in renal biomarker and smaRT-LAMP system
      • 5.1.3.2. Emergence of automated analyzers for urinary tract infection screening
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of awareness about routine health checkup and limited skilled laboratory workforce
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Product: Extensive use of collection cups for the simple and hygienic collection of urine samples for medical diagnostics
    • 5.2.2. End-Use: Increasing use in clinical laboratories for screening and diagnosing various disorders
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Urinalysis Market, by Product

  • 6.1. Introduction
  • 6.2. Consumables
    • 6.2.1. Collection Cups
    • 6.2.2. Reagents
    • 6.2.3. Urine Strips/Dipsticks
  • 6.3. Instruments

7. Urinalysis Market, by Test Type

  • 7.1. Introduction
  • 7.2. Biochemical Urinalysis
  • 7.3. Pregnancy & Fertility Tests
  • 7.4. Sediment Urinalysis

8. Urinalysis Market, by Application

  • 8.1. Introduction
  • 8.2. Diabetes
  • 8.3. Hypertension
  • 8.4. Kidney Diseases
  • 8.5. Liver Diseases
  • 8.6. Urinary Tract Infections

9. Urinalysis Market, by End-Use

  • 9.1. Introduction
  • 9.2. Clinical Laboratories
  • 9.3. Home Healthcare
  • 9.4. Hospitals
  • 9.5. Research & Academics

10. Americas Urinalysis Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Urinalysis Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Urinalysis Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
    • 13.3.1. AixMed and CorePlus Collaborate on Innovative Urine Analysis Research
    • 13.3.2. Toyoda Gosei Invests in Yuurea Inc. for Advancement in Urine Analysis Technology
    • 13.3.3. Medtronic's Strategic Initiative to Address Urinary Incontinence with New Venture
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 77 Elektronika Kft.
  • 2. Abbott Laboratories
  • 3. ACON Laboratories, Inc. by Inverness Medical
  • 4. AdvaCare Pharma
  • 5. Alphatec Scientific E.I.R.L.
  • 6. Analyticon Biotechnologies GmbH by BRAIN Biotech AG
  • 7. Anamol Laboratories Pvt. Ltd.
  • 8. ARKRAY, Inc.
  • 9. Beckman Coulter, Inc. by Danaher Corporation
  • 10. Becton, Dickinson, and Company
  • 11. Bio-Rad Laboratories, Inc.
  • 12. Bioway Biotechnology Co., Ltd.
  • 13. Cardinal Health, Inc.
  • 14. Contec Medical Systems Co., Ltd.
  • 15. Dirui Industrial Co., Ltd.
  • 16. EKF DIAGNOSTICS HOLDINGS PLC
  • 17. Erba Group
  • 18. F. Hoffmann-La Roche Ltd.
  • 19. Kova International, Inc. by LGC Limited
  • 20. MACHEREY-NAGEL GmbH & Co. KG
  • 21. Medsource Ozone Biomedicals Pvt. Ltd.
  • 22. Quidel Corporation
  • 23. Randox Laboratories Ltd.
  • 24. Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
  • 25. Siemens Healthcare GmbH
  • 26. Sweet Cures Nutra
  • 27. Sysmex Corporation
  • 28. Teco Diagnostics
  • 29. Thermo Fisher Scientific Inc.
  • 30. URIT Medical Electronic Group Co., Ltd
  • 31. Woodley Equipment Company Ltd.

LIST OF FIGURES

  • FIGURE 1. URINALYSIS MARKET RESEARCH PROCESS
  • FIGURE 2. URINALYSIS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. URINALYSIS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL URINALYSIS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL URINALYSIS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. URINALYSIS MARKET DYNAMICS
  • TABLE 7. GLOBAL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL URINALYSIS MARKET SIZE, BY CONSUMABLES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL URINALYSIS MARKET SIZE, BY COLLECTION CUPS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL URINALYSIS MARKET SIZE, BY REAGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL URINALYSIS MARKET SIZE, BY URINE STRIPS/DIPSTICKS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL URINALYSIS MARKET SIZE, BY INSTRUMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL URINALYSIS MARKET SIZE, BY BIOCHEMICAL URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL URINALYSIS MARKET SIZE, BY PREGNANCY & FERTILITY TESTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL URINALYSIS MARKET SIZE, BY SEDIMENT URINALYSIS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL URINALYSIS MARKET SIZE, BY DIABETES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL URINALYSIS MARKET SIZE, BY HYPERTENSION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL URINALYSIS MARKET SIZE, BY KIDNEY DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL URINALYSIS MARKET SIZE, BY LIVER DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL URINALYSIS MARKET SIZE, BY URINARY TRACT INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL URINALYSIS MARKET SIZE, BY CLINICAL LABORATORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL URINALYSIS MARKET SIZE, BY HOME HEALTHCARE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. GLOBAL URINALYSIS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 28. GLOBAL URINALYSIS MARKET SIZE, BY RESEARCH & ACADEMICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. AMERICAS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 34. AMERICAS URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 38. ARGENTINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 39. ARGENTINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. BRAZIL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. BRAZIL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 48. CANADA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 49. CANADA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. MEXICO URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. MEXICO URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. UNITED STATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 60. UNITED STATES URINALYSIS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 66. ASIA-PACIFIC URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. AUSTRALIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. AUSTRALIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 75. CHINA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 76. CHINA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. INDIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. INDIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. INDONESIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 86. INDONESIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. JAPAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. JAPAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 95. MALAYSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 96. MALAYSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. PHILIPPINES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. PHILIPPINES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. SINGAPORE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 106. SINGAPORE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. SOUTH KOREA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 111. SOUTH KOREA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 115. TAIWAN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 116. TAIWAN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 120. THAILAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 121. THAILAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 125. VIETNAM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 126. VIETNAM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 131. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 132. EUROPE, MIDDLE EAST & AFRICA URINALYSIS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 136. DENMARK URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 137. DENMARK URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 141. EGYPT URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 142. EGYPT URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. FINLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 147. FINLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 151. FRANCE URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 152. FRANCE URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 156. GERMANY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 157. GERMANY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 161. ISRAEL URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 162. ISRAEL URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. ITALY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 167. ITALY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 171. NETHERLANDS URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 172. NETHERLANDS URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 176. NIGERIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 177. NIGERIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 181. NORWAY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 182. NORWAY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. POLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 187. POLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 191. QATAR URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 192. QATAR URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 196. RUSSIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 197. RUSSIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 201. SAUDI ARABIA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 202. SAUDI ARABIA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 206. SOUTH AFRICA URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 207. SOUTH AFRICA URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 211. SPAIN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 212. SPAIN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 216. SWEDEN URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 217. SWEDEN URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 221. SWITZERLAND URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 222. SWITZERLAND URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 226. TURKEY URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 227. TURKEY URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED ARAB EMIRATES URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM URINALYSIS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM URINALYSIS MARKET SIZE, BY CONSUMABLES, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM URINALYSIS MARKET SIZE, BY TEST TYPE, 2018-2030 (USD MILLION)
  • TABLE 236. UNITED KINGDOM URINALYSIS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 237. UNITED KINGDOM URINALYSIS MARKET SIZE, BY END-USE, 2018-2030 (USD MILLION)
  • TABLE 238. URINALYSIS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 239. URINALYSIS MARKET, FPNV POSITIONING MATRIX, 2023